Skip to main
WAY

WAY Stock Forecast & Price Target

WAY Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 47%
Buy 47%
Hold 5%
Sell 0%
Strong Sell 0%

Bulls say

Waystar Holding is expected to continue its strong growth in the healthcare industry, driven by its innovative AI and revenue cycle technology solutions, cross-selling opportunities from its recent acquisition of Iodine, and strong market presence. Although there are potential challenges and concerns, including high debt and ownership by PE/VC firms, Waystar's strong performance and guidance, as well as the projected value of $33 per share, make it a top choice for hospital executives seeking efficient and effective solutions.

Bears say

Waystar Holding is facing challenges with retaining and adding new members in a highly competitive and rapidly evolving market. Despite its differentiated technology and potential for time and cost savings for healthcare providers, the company's valuation is trading at a discount to its peers. The latest model update shows lowered revenue and EBITDA estimates, resulting in a lowered price target, but we believe near-term drivers and potential for cross-selling opportunities, such as through the recent cyberattack on competitor Change Healthcare, could benefit Waystar in the long term.

WAY has been analyzed by 19 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 47% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waystar Holding Corp (WAY) Forecast

Analysts have given WAY a Buy based on their latest research and market trends.

According to 19 analysts, WAY has a Buy consensus rating as of Jul 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.26, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.26, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waystar Holding Corp (WAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.